Home > Insider Trading > Filing (0001209191-15-033440)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1179357	B Caroline Manogue	C/O Endo International Plc Minerva House, Simmonscourt Road Ballsbridge, Dublin 4 L2	Exec. V.p.,Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2015-04-07	503	$20.61	43,603	No	4	M	Direct
Ordinary Shares	Disposition	2015-04-07	503	$91.90	43,100	No	4	S	Direct
Ordinary Shares	Acquisiton	2015-04-08	36,429	$20.61	79,529	No	4	M	Direct
Ordinary Shares	Acquisiton	2015-04-08	36,609	$33.98	116,138	No	4	M	Direct
Ordinary Shares	Acquisiton	2015-04-08	32,021	$34.70	148,159	No	4	M	Direct
Ordinary Shares	Disposition	2015-04-08	105,059	$91.90	43,100	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2015-04-07	503	$0.00	503	$20.61
Ordinary Shares	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2015-04-08	36,429	$0.00	36,429	$20.61
Ordinary Shares	2010 Stock Incentive Plan Stock Options (NQ)	Disposition	2015-04-08	36,609	$0.00	36,609	$33.98
Ordinary Shares	2010 Stock Incentive Plan Stock Options (NQ)	Disposition	2015-04-08	32,021	$0.00	32,021	$34.70

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
36,429	2020-02-19	No	4	M	Direct
0	2020-02-19	No	4	M	Direct
0	2021-02-23	No	4	M	Direct
10,673	2022-02-22	No	4	M	Direct

Footnotes

On March 9, 2015, in connection with her personal financial planning, Ms. Manogue placed 118,673 of the shares underlying her stock options into a 10b5-1 pre-set selling program (the "Manogue Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Manogue Pre-Set Selling Program, which leaves 13,111 remaining shares (underlying options) in the current Manogue Pre-Set Selling Program.
Ms. Manogue's stock options that were granted under the 2004 Stock Incentive Plan on February 19, 2010 were generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014.
These securities were granted to Ms. Manogue in consideration of her services as the Executive Vice President, Chief Legal Officer of the registrant.
Ms. Manogue's stock options that were granted under the 2010 Stock Incentive Plan on February 23, 2011 were generally exercisable 25% per year on each of February 23, 2012, February 23, 2013, February 23, 2014 and February 23, 2015.
Ms. Manogue's stock options that were granted under the 2010 Stock Incentive Plan on February 22, 2012 are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016.
The 10,673 stock options remaining under this award granted on February 22, 2012 were un-vested as of March 9, 2015 and were therefore not included in the Manogue Pre-Set Selling Program.